Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ER[beta] and Mutant p53

The absence of effective therapeutic targets and aggressive nature of triple- negative breast cancer (TNBC) renders this disease subset difficult to treat. Although estrogen receptor beta (ER[beta]) is expressed in TNBC, studies on its functional role have yielded inconsistent results. However, rece...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2023-04, Vol.28 (4), p.358
Hauptverfasser:	Scarpetti, Lauren, Oturkar, Chetan C, Juric, Dejan, Shellock, Maria, Malvarosa, Giuliana, Post, Kathryn, Isakoff, Steven, Wang, Nancy, Nahed, Brian, Oh, Kevin, Das, Gokul M, Bardia, Aditya
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Case studies Estrogen Health aspects Metastasis Pharmaceutical industry Tamoxifen Tumor proteins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!